Literature DB >> 16968323

Traditional Chinese medicine in cancer care: perspectives and experiences of patients and professionals in China.

W Xu1, A D Towers, P Li, J-P Collet.   

Abstract

Although traditional Chinese medicine (TCM) is widely used in Chinese cancer centres, it is a brand new area for formal scientific evaluation. As the first step of developing a research programme on clinical evaluation of TCM for cancer patients, we conducted a qualitative study to explore the perspectives and experiences of Chinese cancer patients and TCM professionals. Twenty-eight persons participated in two cancer patient focus groups and one professional focus group. Semi-structured interviews were audiotaped, transcribed and translated. Textual transcripts and field notes underwent inductive thematic analysis. We found that patients' decision to use TCM for cancer is a self-help process with a deep cultural grounding, which is related to the traditional Chinese philosophy of life. Participants perceived TCM to be an effective and harmless therapy. They highly valued the fact that TCM is tailored to patients, and believed it was the basis of an optimal and safe treatment. Participants also highlighted the long-term positive effects, the benefit of group interventions and the low cost as important features of TCM. Subjects believed that conducting clinical research would be crucial for the recognition and dissemination of TCM in Western countries. The findings of this study are expected to contribute to the knowledge base on the current TCM use for cancer in China, and to provide useful information for developing future clinical research in this area in Western countries.

Entities:  

Mesh:

Year:  2006        PMID: 16968323     DOI: 10.1111/j.1365-2354.2006.00685.x

Source DB:  PubMed          Journal:  Eur J Cancer Care (Engl)        ISSN: 0961-5423            Impact factor:   2.520


  63 in total

Review 1.  Views on traditional Chinese medicine amongst Chinese population: a systematic review of qualitative and quantitative studies.

Authors:  Vincent C H Chung; Polly H X Ma; Chun Hong Lau; Samuel Y S Wong; Eng Kiong Yeoh; Sian M Griffiths
Journal:  Health Expect       Date:  2012-05-31       Impact factor: 3.377

Review 2.  Traditional Chinese medication for cardiovascular disease.

Authors:  Pan-Pan Hao; Fan Jiang; Yu-Guo Chen; Jianmin Yang; Kai Zhang; Ming-Xiang Zhang; Cheng Zhang; Yu-Xia Zhao; Yun Zhang
Journal:  Nat Rev Cardiol       Date:  2014-11-11       Impact factor: 32.419

Review 3.  Network Pharmacology in Research of Chinese Medicine Formula: Methodology, Application and Prospective.

Authors:  Ting-Ting Luo; Yuan Lu; Shi-Kai Yan; Xue Xiao; Xiang-Lu Rong; Jiao Guo
Journal:  Chin J Integr Med       Date:  2019-04-02       Impact factor: 1.978

4.  2-(2-nitrobenzylidene) indolin-3-one compound inhibits transmembrane prostate androgen-induced protein (TMEPAI) expression and cancer cell proliferation.

Authors:  Yuyin Li; Jianjun Wang; Ning Song; Feihong Zeng; Miaomiao Zhao; Ali Wang; Yue Chen; Lei Jing; Peng Yu; Aipo Diao
Journal:  Cell Prolif       Date:  2018-08-02       Impact factor: 6.831

5.  Clinical and psychometric validation of the quality of life assessment system for advanced gastric cancer based on traditional Chinese medicine.

Authors:  Peng Quan; Pei-Yong Zheng; Sheng-Fu You; Yong-Qiang Hua; Yi Song; Tao Liu; Chong-Hua Wan; Jin-Gen Lu
Journal:  Chin J Integr Med       Date:  2016-06-14       Impact factor: 1.978

6.  Long-Term Effectiveness of Combined Treatment with Traditional Chinese Medicine and Western Medicine on the Prognosis of Patients with Lung Cancer.

Authors:  Woung-Ru Tang; Sien-Hung Yang; Chih-Teng Yu; Chin-Chou Wang; Sheng-Teng Huang; Tzu-Hsin Huang; Ming-Chu Chiang; Yue-Cune Chang
Journal:  J Altern Complement Med       Date:  2016-03       Impact factor: 2.579

7.  Sijunzi decoction-treated rat serum induces apoptosis of side population cells in gastric carcinoma.

Authors:  Jianguang Jia; Yiyu Qin; Ligong Zhang; Chenxu Guo; Yaguo Wang; Xicheng Yue; Jun Qian
Journal:  Exp Ther Med       Date:  2017-11-24       Impact factor: 2.447

8.  Methodology guideline for clinical studies investigating traditional Chinese medicine and integrative medicine: executive summary.

Authors:  Jian-Ping Liu; Ke-Ji Chen
Journal:  Complement Ther Med       Date:  2015-10       Impact factor: 2.446

9.  An elderly patient with advanced lung cancer achieved long-term survival using Chinese medicine: An alternative treatment strategy for cancer patients aged 80 or older without a tissue confirmed diagnosis.

Authors:  Rui Liu; Shu-Lin He; Yoshiro Hirasaki; Hong-Gang Zheng; Bao-Jin Hua
Journal:  Chin J Integr Med       Date:  2015-11-23       Impact factor: 1.978

10.  Cancer patients' attitudes towards Chinese medicine: a Hong Kong survey.

Authors:  Yuen-chi Lam; Chung-wah Cheng; Heng Peng; Chun-key Law; Xianzhang Huang; Zhaoxiang Bian
Journal:  Chin Med       Date:  2009-12-30       Impact factor: 5.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.